The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • No CSPEC related information was provided by the message!

  • See Evidence submitted by expert panel for details.

Variant: NM_000038.6(APC):c.995G>A (p.Arg332Gln)

CA016051

187754 (ClinVar)

Gene: APC
Condition: familial adenomatous polyposis 1
Inheritance Mode: Autosomal dominant inheritance
UUID: 6c80822d-a69a-46c1-ada2-dc79abafcbf9
Approved on: 2023-02-18
Published on: 2023-03-14

HGVS expressions

NM_000038.6:c.995G>A
NM_000038.6(APC):c.995G>A (p.Arg332Gln)
NC_000005.10:g.112819027G>A
CM000667.2:g.112819027G>A
NC_000005.9:g.112154724G>A
CM000667.1:g.112154724G>A
NC_000005.8:g.112182623G>A
NG_008481.4:g.131507G>A
ENST00000257430.9:c.995G>A
ENST00000257430.8:c.995G>A
ENST00000507379.5:c.941G>A
ENST00000508376.6:c.995G>A
ENST00000508624.5:c.*317G>A
ENST00000512211.6:c.995G>A
NM_000038.5:c.995G>A
NM_001127510.2:c.995G>A
NM_001127511.2:c.941G>A
NM_001354895.1:c.995G>A
NM_001354896.1:c.995G>A
NM_001354897.1:c.1025G>A
NM_001354898.1:c.920G>A
NM_001354899.1:c.911G>A
NM_001354900.1:c.818G>A
NM_001354901.1:c.818G>A
NM_001354902.1:c.964-242G>A
NM_001354903.1:c.934-242G>A
NM_001354904.1:c.859-242G>A
NM_001354905.1:c.757-242G>A
NM_001354906.1:c.146G>A
NM_001127510.3:c.995G>A
NM_001127511.3:c.941G>A
NM_001354895.2:c.995G>A
NM_001354896.2:c.995G>A
NM_001354897.2:c.1025G>A
NM_001354898.2:c.920G>A
NM_001354899.2:c.911G>A
NM_001354900.2:c.818G>A
NM_001354901.2:c.818G>A
NM_001354902.2:c.964-242G>A
NM_001354903.2:c.934-242G>A
NM_001354904.2:c.859-242G>A
NM_001354905.2:c.757-242G>A
NM_001354906.2:c.146G>A
More

Benign

Met criteria codes 3
BS2 BS1 BP1
Not Met criteria codes 1
PM2

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
InSiGHT Hereditary Colorectal Cancer/Polyposis VCEP
The c.995G>A variant in APC is a missense variant predicted to cause substitution of Arginine by Glutamine at amino acid 332 (p.Arg332Gln). This variant has been observed in heterozygous state in >100 healthy unrelated adult individuals worth ≥ 10 healthy individual points in total (BS2; Ambry Genetics, Invitae, GeneDX internal data). The allele frequency of the c.995G>A variant in APC is 0.02% for the African sub-population (5/23604 alleles) in the non-cancer dataset from gnomAD (v2.1.1), which is higher than the ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis Variant Curation Expert Panel (HCCP VCEP) threshold (≥ 0.001%) for BS1, and therefore meets BS1. APC is defined by the HCCP VCEP as a gene for which primarily truncating variants are known to cause disease (BP1). In summary, this variant meets the criteria to be classified as Benign for FAP based on the ACMG/AMP criteria applied, as specified by the HCCP VCEP: BS1, BS2 and BP1 (VCEP specifications version 1; date of approval: 12/12/2022).
Met criteria codes
BS2
This variant has been observed in heterozygous state in >100 healthy unrelated adult individuals worth ≥ 10 healthy individual points in total (BS2; Ambry Genetics, Invitae, GeneDX internal data).
BS1
The allele frequency of the c.420G>C (p.Glu140Asp) variant in APC is 0.02% for the African subpopulation (5/23604 allels) from gnomAD non-cancer dataset (v2.1.1), which is higher than the ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis threshold (≥ 0.001%) for BS1, and therefore meets this criterion (BS1).
BP1
APC, in which the variant was identified, is defined by the ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis VCEP as a gene for which primarily truncating variants are known to cause disease (BP1).
Not Met criteria codes
PM2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.